We are live on
!
Find out more
ZVSA
ZyVersa Therapeutics
ZVSA
ZVSA
Delisted
ZVSA was delisted on the 16th of July, 2025.
7 hedge funds and large institutions have $43.9K invested in ZyVersa Therapeutics in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.51% less ownership
Funds ownership: 3.23% → 2.72% (-0.51%)
13% less funds holding
Funds holding: 8 → 7 (-1)
49% less capital invested
Capital invested by funds: $86.2K → $43.9K (-$42.3K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$27.2K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$24.5K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$2 |
Top Sellers
| 1 |
Citigroup
New York
|
-$37.1K |
| 2 |
Renaissance Technologies
New York
|
-$13.7K |
| 3 |
VF
Virtu Financial
New York
|
-$8.72K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.5K |